NCT04104243

Brief Summary

The goal of this study is to address the risk of diabetes among men by creating a Diabetes Prevention Program (DPP) tailored to men.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
301

participants targeted

Target at P75+ for not_applicable type-2-diabetes

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 26, 2019

Completed
1.9 years until next milestone

Study Start

First participant enrolled

August 9, 2021

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 7, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2025

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

March 30, 2026

Completed
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

3.5 years

First QC Date

September 19, 2019

Results QC Date

February 9, 2026

Last Update Submit

March 27, 2026

Conditions

Keywords

Pre-DiabetesMen's HealthType 2 DiabetesRacial Disparities

Outcome Measures

Primary Outcomes (2)

  • Percent Weight Change Through 16 Sessions

    The percent weight change through 16 sessions was compared. Mean percent weight change for each arm for all intent-to-treat (ITT) participants (i.e.. attended \>=0 sessions), as well as those who were considered "Engaged" (i.e., attended \>=4 sessions) or "Retained" (i.e., attended \>=9 sessions), through 16 scheduled sessions, was determined. All data is crude and unadjusted with no imputation.

    Up to 6 months, after the delivery of the 16th session (end of the core phase)

  • Percent Weight Change Through the 12 Month Trial

    The percent weight change through 12 months was compared. Mean percent weight change for each arm for all intent-to-treat (ITT) participants (i.e., attended \>=0 sessions), as well as those who were considered "Engaged" (i.e., attended \>=4 sessions) or "Retained" (i.e., attended \>=9 sessions), through 12 months, was determined. All data is crude and unadjusted with no imputation.

    12 Months (At end of maintenance phase)

Secondary Outcomes (2)

  • Engagement of Men in Power-Up vs Standard National Diabetes Prevention Program

    6 Months (At end of the core phase)

  • Retention of Men in Power-Up vs Standard National Diabetes Prevention Program

    12 Months (At end of the maintenance phase)

Study Arms (2)

Power-Up

EXPERIMENTAL

Participants randomized to this arm will undergo 16 classes tailored for men, that discuss food choices, physical activity, and managing stress over 6 months, which are called the core, and 6 classes over the following 6 months, which is called the maintenance phase.

Other: Men-Tailored DPP (Power-Up)

Standard NDPP (National Diabetes Prevention Program)

NO INTERVENTION

Participants randomized to this arm will undergo 16 mixed gender classes that discuss food choices, physical activity, and managing stress over 6 months which are called the core and 6 classes over the following 6 months which is called the maintenance phase.

Interventions

Evaluating whether a diabetes prevention program (DPP) tailored for men (Power-Up) will show better or similar percent weight loss and retention than a standard mixed-gender DPP

Power-Up

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsWe are only enrolling men.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old
  • Most recent HbA1c: 5.7%-6.4% (within last year) or Diabetes Risk Score \>= 5
  • Most recent BMI ≥ 25 (within last 6 months)
  • Access to a device that can join sessions virtually either through a virtual conferencing application
  • Have valid address and telephone contact information
  • Have no plans to change their health system/primary care provider or move from their current, NYC area, address in the next year

You may not qualify if:

  • Not physically able or willing to attend virtual, group-based sessions
  • Unable to provide informed consent by telephone
  • Unable or unwilling to complete baseline telephone surveys or follow-up surveys in English or Spanish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Albert Einstein College of Medicine

The Bronx, New York, 10461, United States

Location

Related Publications (4)

  • Walker EA, Weiss L, Gary-Webb TL, Realmuto L, Kamler A, Ravenell J, Tejeda C, Lukin J, Schechter CB. Power Up for Health: Pilot Study Outcomes of a Diabetes Prevention Program for Men from Disadvantaged Neighborhoods. Am J Mens Health. 2018 Jul;12(4):989-997. doi: 10.1177/1557988318758787. Epub 2018 Mar 15.

    PMID: 29540129BACKGROUND
  • Realmuto L, Kamler A, Weiss L, Gary-Webb TL, Hodge ME, Pagan JA, Walker EA. Power Up for Health-Participants' Perspectives on an Adaptation of the National Diabetes Prevention Program to Engage Men. Am J Mens Health. 2018 Jul;12(4):981-988. doi: 10.1177/1557988318758786. Epub 2018 Mar 15.

    PMID: 29540130BACKGROUND
  • Gary-Webb TL, Walker EA, Realmuto L, Kamler A, Lukin J, Tyson W, Carrasquillo O, Weiss L. Translation of the National Diabetes Prevention Program to Engage Men in Disadvantaged Neighborhoods in New York City: A Description of Power Up for Health. Am J Mens Health. 2018 Jul;12(4):998-1006. doi: 10.1177/1557988318758788. Epub 2018 Mar 15.

    PMID: 29540131BACKGROUND
  • Chambers EC, Walker EA, Schechter C, Gil E, Herbert T, Diaz K, Gonzalez J. Virtual Diabetes Prevention Program Tailored to Increase Participation of Black and Latino Men: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Jun 24;14:e64405. doi: 10.2196/64405.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Glucose Intolerance

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperglycemia

Results Point of Contact

Title
Earle C. Chambers, PhD, MPH
Organization
Albert Einstein College of Medicine

Study Officials

  • Earle Chambers, PhD

    Albert Einstein College of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: There will be 6 intervention cycles. Approximately 50 men will be randomized 1:1 to each study arm. There will be 4 control cycles for every intervention workshop. Therefore we will have 6 intervention workshops and 24 control workshops. The participants will be randomized to either undergo Power-Up or standard Diabetes Prevention Program sessions.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2019

First Posted

September 26, 2019

Study Start

August 9, 2021

Primary Completion

February 7, 2025

Study Completion

February 7, 2025

Last Updated

March 30, 2026

Results First Posted

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations